ICL vs SMG: ICL Israel Chemicals and Scotts Miracle-Gro compared
The short version
From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.
- ICL Israel Chemicals is the larger company, worth $6.1B, about 2.1 times Scotts Miracle-Gro.
- ICL Israel Chemicals grew revenue faster over the last year (+4.6% vs +1.1%).
- Scotts Miracle-Gro keeps more of each dollar of revenue as operating profit (11.0% vs 8.1%).
- On earnings, Scotts Miracle-Gro is the cheaper stock (14.2x vs 27.9x).
Side by side
The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.
| Measure | ICL | SMG |
|---|---|---|
| Market cap | $6.1B | $2.9B |
| Share price | $5.02 | $49.86 |
| Revenue (last fiscal year) | $7.2B | $3.4B |
| Free cash flow (last fiscal year) | — | $274M |
| Revenue growth, last year | +4.6% | +1.1% |
| Revenue growth per year, last 5 fiscal years | +0.7% | -8.8% |
| Operating margin | 8.1% | 11.0% |
| Net margin | 3.2% | 2.1% |
| Return on equity | 3.8% | — |
| P/E (trailing) | 27.9x | 14.2x |
| Price / free cash flow | 47.1x | 10.5x |
| EV / EBITDA | 6.98x | 12.0x |
| FCF growth the price implies | — | -3.5% |
| Dividend yield | 4.0% | 5.5% |
| Debt / equity | 1.03x | — |
| Fundamental grade | D | D |
| Superinvestors holding it | 1 | 7 |
| Insider purchases, last 12 months | 0 | 1 |
Results from SEC filings
Revenue and free cash flow by fiscal year, from each company's 10-K filings.
ICL Israel Chemicals
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $7.0B | — | 17.4% |
| 2022 | $10.0B | — | 35.1% |
| 2023 | $7.5B | — | 15.1% |
| 2024 | $6.8B | — | 11.3% |
| 2025 | $7.2B | — | 8.1% |
Scotts Miracle-Gro
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $4.9B | $165M | 14.7% |
| 2022 | $3.9B | -$242M | -11.1% |
| 2023 | $3.6B | $438M | -4.9% |
| 2024 | $3.6B | $584M | 5.9% |
| 2025 | $3.4B | $274M | 10.5% |
Where the revenue comes from
ICL Israel Chemicals · by segments, 2025
Phosphate Solutions$2.3B31%
Growing Solutions$2.1B27%
Potash$1.7B23%
Industrial Products$1.3B17%
Other Activities$183M2%
Scotts Miracle-Gro · by segments, 2025
Reportable segment total$3.2B93%
Other non-reportable operating segment$254M7%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open ICL in InvestinglyQuestions
Which is bigger, ICL Israel Chemicals or Scotts Miracle-Gro?
ICL Israel Chemicals (ICL), at $6.1B against $2.9B.
Is ICL or SMG cheaper?
By trailing P/E, Scotts Miracle-Gro (14.2x) is cheaper than ICL Israel Chemicals (27.9x). A lower multiple can also mean the market expects less growth.
Which grows faster, ICL or SMG?
ICL Israel Chemicals: revenue grew +4.6% over the last year, against +1.1%.
Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.